properties. In 2008, Graf emphasised the need to re-wire our ideas of haematopoiesis. 3 In 2009, we argued that a continuum of fates is available to HSC 2, 4 and our view of the architecture of haematopoiesis was the pair-wise model, shown in Figure 1 . In contrast to tree-like models, this model envisages HSC as being able to commit directly to a lineage option without the need to sequentially restrict alternative fates (see later). Another aspect of this model is its emphasis on close relationships between cell lineages. The lineage options available to bi-potent cell populations, as revealed by colony-forming assays of bone marrow cells using semi-solid medium, and the incomplete sets of options available to other progenitor populations were assumed to indicate close relationships between pathways. Sets of potencies that overlapped were combined and shown in our model. 2, 5 The shared cell usage of transcription factors and responsiveness to promiscuous cytokines 6 accord with the particular close relationships between cell lineages. Transcription factors can promote the development of a group of adjacent cell types, can suppress the development of cells lying on either side of a fate or set of fates and can divert the development of a progenitor that has provisionally adopted a fate to an adjacent fate. 2 As a result, the concerted action of multiple transcriptions factors might narrow fate trajectories in a centrifugal manner until only one option remains. . One difficulty with compartmentalising cells in this manner is a lack of knowledge about the functions of some of these surface molecules during developmental progression. For example, the cellular functions of CD34, CD48 and CD150, and of markers such as Ly6D and SiglecH that are used to subdivide HPC in the case of early progenitors with lymphoid and myeloid potential (EPLM), are not known. 8, 9 Can HSC be described simply as either LT-HSC or ST-HSC? The first indication that this is not the case was the identification of HSC with lineage biases. Myeloid-and lymphoid-biased mouse HSC have been identified by transferring single cells into irradiated mice. Myeloidbiased HSC express a higher level of CD150 than lymphoid-biased HSC and exclude the DNA-binding dye Hoechst 33342 more effectively. The surface markers CD41 and CD86, respectively, have also been used to denote myeloid-versus lymphoid-biased HSC. 10, 11 Myeloid-biased HSC predominate in aged mice, in which the supply of lymphoid-biased HSC appear to have been exhausted as a result of more extensive proliferation. 12 Using reconstitution experiments, the Jacobsen group described a mouse HSC that was biased towards platelets and myeloid cells, expressing von Willebrand factor and requiring thrombopoietin for its maintenance. Cells that did not express von-Willebrand factor were lymphoid-biased. 13 Mouse HSC express the receptors for macrophage colony-stimulating factor (M-CSF) and erythropoietin (Epo) and the fms-like tyrosine kinase 3 (Flt3), which binds the lympho/myeloid-affiliated Flt3 ligand (Flt3L). [14] [15] [16] [17] The receptors for M-CSF (CD115) and Epo (Epo-R) are expressed by HSC; some HSC co-express the M-CSF receptor and Flt3 and co-expression of the Epo-R and Flt3 mRNAs was rarely seen. 15 The CMP population is viewed as giving rise to all myeloid cells. However, the use of an optimised single cell in vitro assay has shown that human CMP are a mixture of cells with either myeloid, erythroid or megakaryocyte developmental potential. 18 Hoppe and colleagues have analysed RNA expression data from individual murine HSC throughout their development towards megakaryocytic, erythroid and myeloid cells and concluded that CMP are a mixture of bipotent granulocyte/monocyte (GMP) and megakaryocyte/erythroid (MEP)
progenitors. 23 Paul and colleagues have examined, at the single cell level, the transcriptional heterogeneity and lineage commitment of myeloid progenitors from normal as well as mice in which myelopoiesis had been perturbed by knocking out the myeloid regulator Cebpα.
Single bone marrow progenitors were sorted into 7 clusters with the transcriptional properties of neutrophils, basophils, eosinophils, monocytes, dendritic cells, erythrocytes and megakaryocytes. In total, 18 different populations were identified with variable degrees of specification towards these pathways. Normally, cells with mixed gene expression profiles
were not observed but were present when Cebpα had been knocked out, revealing that mixed states are possible. 24 These studies using recently-developed single cell genomic analysis highlight the fact that phenotypically ring-fenced populations can nevertheless be genotypically and developmentally heterogeneous.
From all of the above there is the need to move away from a tree-like depiction of haematopoiesis which does not envisage the direct commitment of HSC to a cell type.
Another conclusion from all of the the above is that the distinction between HSC and HPC has become somewhat blurred, and perhaps redundant. HSC can no longer be defined strictly by their lack of a lineage affiliation coupled invariably to a capacity to self-renew.
Additionally, Hofer and colleagues have highlighted that the hallmarks used to delineate HSC and HPC, namely self-renewal and the extent of multi-potency as revealed by cell transplantation experiments and in vitro assays, may not be features that occur naturally in these cells. 25 The nomenclature used to describe LMPP, EPLM and CMP is misleading, particularly that each of these populations is a mixture of cells. Perhaps we should describe all cells that give rise to the haematopoietic system as progenitors that are either multipotent, termed HPC-MP or with a designation regarding their lineage affiliation, for example HPC-E as to erythroid.
The pair-wise model has been annotated in Figure 3 [26] [27] [28] Interestingly, the results obtained from these investigations suggest significant differences between steady-state physiological haematopoiesis and that observed following transplantation into irradiated animals. Thus, while reconstitution of the depleted haematopoietic system after transplantation occurs through the expansion and differentiation of a small number of donor HSC, the normal replenishment of blood cells seems to involve a larger number of HSC clones, which are successively recruited to regenerate mature haematopoietic cells. 28 In addition, steady-state haematopoiesis seems to be sustained to a large extent through the contribution of multi-and oligo-potent HPC, rather than HSC. 28, 29 These differences between physiological and transplantation-based haematopoiesis could be the result of the different engraftment capabilities of various HSC clones and could be consequences of the changes that occur in the haematopoietic niches after irradiation.
Steady state haematopoiesis in adult mice is most often the model that is studied to provide a map of haematopoiesis. But, how blood cell types are produced in early life, during has been proposed for mammalian models. As HSC arise, perhaps the clones generated acquire, or evolve, the uni-potent propensities necessary to generate all the different types of blood and immune cells, to 'set' an established and complete pattern of diversity. Even so and as mentioned above, mixed lineage states were observed when haematopoiesis was perturbed in the adult mouse, by Cebpα knock-out, 24 which may mean that propensities can be re-set in a particular circumstance.
The nature of the trajectories available to HSC
Affiliation of HSC/HPC to a single fate does not preclude there being particular relationships between lineage trajectories. As previously mentioned, the identification of cells that share just two particular lineage options has been a long standing feature of the outcomes from many experiment studies. A prime example of this is that primitive haematopoiesis is bilineage in nature with megakaryocyte/erythroid progenitors emerging in the mouse yolk sac at embryonic day 7.25, along with megakaryocytes and primitive erythroid progenitors. 31 Holtzer argued in favour of bipotent lineage relationships from the point of view that cells can only make either/or type decisions 32 have low-level expression of the mRNAs for Gfi1 and Irf8 and increased expression of these genes coincides with, and appears to be necessary for, neutrophil and monocyte specification, respectively. Accordingly, mixed lineage cells appear to be poised for binary fate choices.
The above investigators have proposed that bi-lineage expression states are meta-stable, due to bursts of alternative lineage gene expression, and are obligatory for cell-fate specification. 33 Velten and colleagues have constructed developmental trajectories by integrating transcriptomic data obtained from single-cell RNA-seq with data from single cell cultures to provide compelling evidence that lineage commitment of human HSC is a continuous process. 30 Genes relating to the degree of transcriptome priming were clustered into modules which were then plotted against the extent of lineage-specific priming. An interesting question is whether there is a hierarchy to the availability of options of HSC.
As early as 1981, Nicola and Johnson argued that commitment to megakaryocyte and erythroid differentiation was an obligatory step during the development of HSC and that erythroid cells were invariably present in mixed colonies of bone marrow-derived cells plated in semi-solid medium. 36 Sanjuan-Pla and colleagues have argued that a platelet-biased stem cell resides at the apex of the haematopoietic hierarchy 13 and in particular that megakaryocytes and HSC share key transcription factors. 37 The myeloid-based model of within HSC specifies myeloid/lymphoid versus myeloid/erythroid fates, respectively. 43 The use of PU.1-GFP mice has shown that M-CSF stimulates expression of PU.1 in some LT-HSC thereby eliciting myeloid lineage specification. 16 As considered later, G-CSF/M-CSF 
Do haematopoietic cytokines instruct cell lineage choice?
The first evidence for a humoral factor that influences haematopoiesis, one that promotes erythropoiesis, was published more than 60 years ago. Since then, a plethora of permissive. An instructive cytokine acts on an un-committed and oligopotent HPC to induce a signaling cascade and activate a genetic program that leads to the commitment of the cell to a particular haematopoietic lineage ( Figure 5 ). In contrast, a permissive cytokine acts as a selection factor, promoting the survival and/or proliferation of some of its progeny. In this latter model, lineage commitment occurs in a cell-autonomous manner and independently of a particular cytokine. Proponents of the permissive model often refer to the commitment of progenitors as "stochastic", a term that has caused some misunderstanding when used in developmental biology.
The discovery of low level and promiscuous expression of lineage-specific genes in early HPC (lineage priming) 48 led to the hypothesis that random initiation of a self-reinforcing lineage-specific genetic program leads to the commitment of HPC to that lineage and to the subsequent expression of cytokine receptors that then facilitate the permissive function of the corresponding cytokines ( Figure 5 , right panel). However, this initial lineage specification could be the result of other extra-cellular cues or epigenetic assymetries originating from the progenitor's developmental history; factors that cannot be considered as truly random, but rather as deterministic. Therefore, when discussing the permissive model, we herein refer to the lineage commitment of HPC merely as independent of the cytokine in question.
Whether a cytokine is instructive or permissive for a lineage, its presence or absence will influence the production of lineage-committed HPC in vivo or in vitro, but its exact mode of action is unknown in most cases. Identifying the precise role of cytokines in haematopoietic cell fate decisions is clinically significant, as this might lead to interventions to increase haematopoietic cell production, but is technically challenging. This has led to apparently contradictory results and has fueled a long-standing and lively debate. Genetic deletion of cytokines or their receptors reduces the developmental output of haematopoietic lineages regulated by the corresponding cytokines, with the reductions ranging from modest to severe.
However, deletion of a single cytokine or cytokine receptor never results in a complete absence of a haematopoietic lineage. This has been considered as evidence for the permissive action of cytokines but could also be the result of compensatory mechanisms and of some level of redundancy in vivo. Over-expression of anti-apoptotic genes, such as Bcl2, has sometimes been sufficient to rescue the differentiation of HPC to the affected lineage, as seen with T cell development in the absence of IL-7. 49 These results identify a role for these cytokines as survival factors for the corresponding HPC and provide evidence for their . In keeping with this, the "cancer stem cell" theory has recently been discussed as the probable root cause of cancer. In this view, the genotypic alteration occurs in the stem cell compartment and the aberrant cancer stem cell produces abundant malignant cells of a specific phenotype.
As argued previously, a landscape exists for normal haematopoiesis whereby HSC are able to commit directly to a particular cell lineage. We might presume that these cells are equally competent to commit to any one of the array of pathway options, by virtue of having a high degree of transcriptional plasticity. Hence, HSC are versatile in their capacity to populate the mature cell compartments. By contrast, the leukaemia stem cell (LSC) appears to be biased towards or more competent to commit to just one lineage. Estimates of the proportion of LSC within a leukaemia, and CSC within other cancers, vary from very few up to 25%. However, the important point is that, whether few or a high percentage, they all give rise to one cell type, that is possibly related to their characteristic genetic lesion(s). A loss of versatility regarding the capacity of LSC to commit to any one of a number of lineage options might well be a cardinal feature of leukaemia, and other cancers (see Figure 6 ). Another possiblilty is that some of the progeny of a LSC can drive the leukaemia whereas others are nontumorigenic and cannot: a clone that is biased or committed directly to one pathway is generating the bulk of the leukaemia cells. The epigenome is of interest regarding both possibilities as, in part, cancers are epigenetically-driven, whereby dysregulation of histone modifications, DNA methylation and miRNAs act in concert with genetic abnormalities.
Concluding remarks
New findings support a movement away from describing the haematopoietic system as a strictly hierarchical tree lineage with intermediate and oligo-potent progenitors for each mature cell type. A continuum of lineage options appears to be directly available to HSC.
Whilst HSC can affiliate to a lineage pathway immediately, their progeny remain versatile.
HPC are able to step sideways developmentally, to follow a route to a different end cell.
Perhaps we have come full circle to Waddington's postulated viewpoint of an epigenetic landscape and, as considered above, he may well be right (Figure 4 LT-HSC to effect myeloid gene expression. 16 Chromatin that is globally devoid of the repressive histone marks (red triangle), such as H3K27me3, is essential to the recruitment of PU.1 as increasing H3K27me3 levels block M-CSF-induced differentiation. 42 Having permissive histone marks (green triangle) is also important. 
